C28H24FN3O6
Neat
517.51
Room Temperature
1628530-38-0; 2-Hydroxy cabozantinib; Cabozantinib oxidation B; Cabozantinib metabolite M16; N-(4-((6, 7-Dimethoxyquinolin-4-yl)oxy)phenyl)-N-(4-fluoro-2-hydroxyphenyl)cyclopropane-1, 1-dicarboxamide; XU28OQ19RG; UNII-XU28OQ19RG; 2-?Hydroxy Cabozantinib; 1, 1-Cyclopropanedicarboxamide, N-(4-((6, 7-dimethoxy-4-quinolinyl)oxy)phenyl)-N'-(4-fluoro-2-hydroxyphenyl)-; N-(4-((6, 7-Dimethoxy-4-quinolinyl)oxy)phenyl)-N'-(4-fluoro-2-hydroxyphenyl)-1, 1-cyclopropanedicarboxamide; Cabozantinib Impurity 60; CHEMBL5936298; SCHEMBL16070066; BDBM381927; US10273211, Compound 16; BS-47871; F77534; 1-N-[4-(6, 7-dimethoxyquinolin-4-yl)oxyphenyl]-1-N'-(4-fluoro-2-hydroxyphenyl)cyclopropane-1, 1-dicarboxamide; N1-[4-(6, 7-dimethoxyquinolin-4-yl)oxyphenyl]-N1'-(4-fluoranyl-2-oxidanyl-phenyl)cyclopropane-1 and 1-dicarboxamide
1-N-[4-(6, 7-dimethoxyquinolin-4-yl)oxyphenyl]-1-N'-(4-fluoro-2-hydroxyphenyl)cyclopropane-1 and 1-dicarboxamide
InChI=1S/C28H24FN3O6/c1-36-24-14-19-21(15-25(24)37-2)30-12-9-23(19)38-18-6-4-17(5-7-18)31-26(34)28(10-11-28)27(35)32-20-8-3-16(29)13-22(20)33/h3-9,12-15,33H,10-11H2,1-2H3,(H,31,34)(H,32,35)